Adipokine protein expression pattern in growth hormone deficiency predisposes to the increased fat cell size and the whole body metabolic derangements

Journal of Clinical Endocrinology and Metabolism

Volumn 93, Issue 6, 2008, Pages 2255-2262

  Ukropec, Jozef ^a   Penesová, Adela ^a   Škopková, Martina ^a   Pura, Mikuláš ^b   Vlček, Miroslav ^a   Rádiková, Žofia ^a   Imrich, Richard ^a   Ukropcová, Barbara ^a   Tajtáková, Mária ^c   Koška, Juraj ^a,f   Zórad, Štefan ^a   Belan, Vítazoslav ^d   Vaňuga, Peter ^b   Payer, Juraj ^d   Eckel, Juergen ^e   Klimeš, Iwar ^a   Gašperíková, Daniela ^a  

^a INSTITUTE OF EXPERIMENTAL ENDOCRINOLOGY   (Slovakia)

^b National Institute of Endocrinology and Diabetology   (Slovakia)

^c P J AFÁRIK UNIVERSITY   (Slovakia)

^d Faculty of Medicine of Comenius University and University Hospital Bratislava   (Slovakia)

^e LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

^f NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ANGIOPOIETIN 2; BRAIN DERIVED NEUROTROPHIC FACTOR; C REACTIVE PROTEIN; CELL PROTEIN; CXCL11 CHEMOKINE; DESMOPRESSIN; EOTAXIN; ESTRADIOL; GAMMA INTERFERON; HYDROCORTISONE; INTERLEUKIN 1BETA; LEVOTHYROXINE; MONOCYTE CHEMOTACTIC PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 3; STEM CELL FACTOR; STROMAL CELL DERIVED FACTOR; TESTOSTERONE ESTER; VASCULOTROPIN;

ABDOMINAL OBESITY; ADOLESCENT; ADULT; ANGIOGENESIS; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GROWTH HORMONE DEFICIENCY; HUMAN; HUMAN TISSUE; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; MALE; NERVOUS SYSTEM DEVELOPMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MICROARRAY; SUBCUTANEOUS FAT; TISSUE DIFFERENTIATION; TISSUE GROWTH;

EID: 45149114204     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2007-2188     Document Type: Article

References (38)

1. Tomlinson JW, Holden N, Hills RK, Wheatley K, Clayton RN, Bates AS, Sheppard MC, Stewart PM 2001 Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet 357:425-431
2. Twickler TB, Cramer MJ, Dallinga-Thie GM, Chapman MJ, Erkelens DW, Koppeschaar HP 2003 Adult-onset growth hormone deficiency: relation of postprandial dyslipidemia to premature atherosclerosis. J Clin Endocrinol Metab 88:2479-2488
3. Salomon F, Cuneo RC, Hesp R, Sonksen PH 1989 The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med 321:1797-1803
4. Rosen T, Bengtsson BA 1990 Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 336:285-288
5. Yuen KC, Frystyk J, White DK, Twickler TB, Koppeschaar HP, Harris PE, Fryklund L, Murgatroyd PR, Dunger DB 2005 Improvement in insulin sensitivity without concomitant changes in body composition and cardiovascular risk markers following fixed administration of a very low growth hormone (GH) dose in adults with severe GH deficiency. Clin Endocrinol (Oxf) 63:428-436
6. Beshyah SA, Johnston DG 1999 Cardiovascular disease and risk factors in adults with hypopituitarism. Clin Endocrinol (Oxf) 50:1-15
7. Carroll PV, Christ ER, Bengtsson BA, Carlsson L, Christiansen JS, Clemmons D, Hintz R, Ho K, Laron Z, Sizonenko P, Sonksen PH, Tanaka T, Thorne M 1998 Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee. J Clin Endocrinol Metab 83:382-395
8. Abdul Shakoor SK, Shalet SM 2003 Effects of GH replacement on metabolism and physical performance in GH deficient adults. J Endocrinol Invest 26:911-918
9. Doga M, Bonadonna S, Gola M, Mazziotti G, Giustina A 2006 Growth hormone deficiency in the adult. Pituitary 9:305-311
10. Johansson JO, Fowelin J, Landin K, Lager I, Bengtsson BA 1995 Growth hormone-deficient adults are insulin-resistant. Metabolism 44:1126-1129
11. Lee SD, Huang CY, Shu WT, Chen TH, Lin JA, Hsu HH, Lin CS, Liu CJ, Kuo WW, Chen LM 2006 Pro-inflammatory states and IGF-I level in ischemic heart disease with low or high serum iron. Clin Chim Acta 370:50-56
12. McCallum RW, Sainsbury CA, Spiers A, Dominiczak AF, Petrie JR, Sattar N, Connell JM 2005 Growth hormone replacement reduces C-reactive protein and large-artery stiffness but does not alter endothelial function in patients with adult growth hormone deficiency. Clin Endocrinol (Oxf) 62:473-479
13. Smotkin-Tangorra M, Anhalt H, Ten S 2006 Growth hormone and premature atherosclerosis in childhood obesity. J Pediatr Endocrinol Metab 19:455-465
14. Kershaw EE, Flier JS 2004 Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89:2548-2556
15. Trayhurn P, Bing C, Wood IS 2006 Adipose tissue and adipokines- energy regulation from the human perspective. J Nutr 136:1935S-1939S
16. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante Jr AW 2003 Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112:1796-1808
17. Corica F, Allegra A, Corsonello A, Buemi M, Calapai G, Ruello A, Nicita Mauro V, Ceruso D 1999 Relationship between plasma leptin levels and the tumor necrosis factor-α system in obese subjects. Int J Obes Relat Metab Disord 23:355-360
18. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa K, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Hanafusa T, Matsuzawa Y 2000 Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20:1595-1599
19. Ridker PM, Hennekens CH, Buring JE, Rifai N 2000 C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342:836-843
20. Pinterova L, Zelezna B, Fickova M, Macho L, Krizanova O, Jezova D, Zorad S 2001 Elevated AT1 receptor protein but lower angiotensin II-binding in adipose tissue of rats with monosodium glutamate-induced obesity. Horm Metab Res 33:708-712
21. Skopkova M, Penesova A, Sell H, Radikova Z, Vlcek M, Imrich R, Koska J, Ukropec J, Eckel J, Klimes I, Gasperikova D 2007 Protein array reveals differentially expressed proteins in subcutaneous adipose tissue in obesity. Obesity (Silver Spring) 15:2396-2406 -
22. De Boer H, Blok GJ, Voerman HJ, De Vries PM, van der Veen EA 1992 Body composition in adult growth hormone-deficient men, assessed by anthropometry and bioimpedance analysis. J Clin Endocrinol Metab 75:833-837
23. Gleeson HK, Souza AH, Gill MS, Wieringa GE, Barretto ES, Barretto-Filho JA, Shalet SM, Aguiar-Oliveira MH, Clayton PE 2002 Lipid profiles in untreated severe congenital isolated growth hormone deficiency through the lifespan. Clin Endocrinol (Oxf) 57:89-95
24. Bonnet F, Vanderschueren-Lodeweyckx M, Eeckels R, Malvaux P 1974 Subcutaneous adipose tissue and lipids in blood in growth hormone deficiency before and after treatment with human growth hormone. Pediatr Res 8:800-805
25. Rosenbaum M, Gertner JM, Leibel RL 1989 Effects of systemic growth hormone (GH) administration on regional adipose tissue distribution and metabolism in GH-deficient children. J Clin Endocrinol Metab 69:1274-1281
26. Ravussin E, Smith SR 2002 Increased fat intake, impaired fat oxidation, and failure of fat cell proliferation result in ectopic fat storage, insulin resistance, and type 2 diabetes mellitus. Ann NY Acad Sci 967:363-378
27. Weyer C, Foley JE, Bogardus C, Tataranni PA, Pratley RE 2000 Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance. Diabetologia 43:1498-1506
28. Avram MM, Avram AS, James WD 2007 Subcutaneous fat in normal and diseased states 3. Adipogenesis: from stem cell to fat cell. J Am Acad Dermatol 56:472-492
29. Rajkumar K, Modric T, Murphy LJ 1999 Impaired adipogenesis in insulin-like growth factor binding protein-1 transgenic mice. J Endocrinol 162:457-465
30. Ramsay TG, White ME, Wolverton CK 1989 Insulin-like growth factor 1 induction of differentiation of porcine preadipocytes. J Anim Sci 67:2452-2459
31. Firth SM, Baxter RC 2002 Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 23:824-854
32. Baxter RC, Butt AJ, Schedlich LJ, Martin JL 2000 Antiproliferative and proapoptotic activities of insulin-like growth factor-binding protein-3. Growth Horm IGF Res 10(Suppl A):S10-S11
33. Wheatcroft SB, Kearney MT, Shah AM, Ezzat VA, Miell JR, Modo M, Williams SC, Cawthorn WP, Medina-Gomez G, Vidal-Puig A, Sethi JK, Crossey PA 2007 IGF-binding protein-2 protects against the development of obesity and insulin resistance. Diabetes 56:285-294
34. Scharf JG, Unterman TG, Kietzmann T 2005 Oxygen-dependent modulation of insulin-like growth factor binding protein biosynthesis in primary cultures of rat hepatocytes. Endocrinology 146:5433-5443
35. Peng XH, Karna P, Cao Z, Jiang BH, Zhou M, Yang L 2006 Cross-talk between epidermal growth factor receptor and hypoxia-inducible factor-1α signal pathways increases resistance to apoptosis by up-regulating survivin gene expression. J Biol Chem 281:25903-25914
36. Wang Y, Wan C, Deng L, Liu X, Cao X, Gilbert SR, Bouxsein ML, Faugere MC, Guldberg RE, Gerstenfeld LC, Haase VH, Johnson RS, Schipani E, Clemens TL 2007 The hypoxia-inducible factor α pathway couples angiogenesis to osteogenesis during skeletal development. J Clin Invest 117:1616-1626
37. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME, Capla JM, Galiano RD, Levine JP, Gurtner GC 2004 Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 10:858-864
38. Hosogai N, Fukuhara A, Oshima K, Miyata Y, Tanaka S, Segawa K, Furukawa S, Tochino Y, Komuro R, Matsuda M, Shimomura I 2007 Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes 56:901-911